These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 11774091

  • 21. Fixed dose combination of lamivudine, stavudine and nevirapine in the treatment of pediatric HIV infection: a preliminary report.
    Pensi T.
    Indian Pediatr; 2007 Jul; 44(7):519-21. PubMed ID: 17684304
    [Abstract] [Full Text] [Related]

  • 22. Effect of highly active antiretroviral therapy on CD4 count and weight in AIDS patients seen at the UITH, Ilorin.
    Olawumi HO, Olatunji PO, Salami AK, Odeigah L, Iseniyi JO.
    Niger J Clin Pract; 2008 Dec; 11(4):312-5. PubMed ID: 19320401
    [Abstract] [Full Text] [Related]

  • 23. [A fixed dose anti-HIV combination for the poor? Triomune].
    Garcia MV, Mukeba-Tshialala D, Vaira D, Moutschen M.
    Rev Med Liege; 2009 Jan; 64(1):32-6. PubMed ID: 19317099
    [Abstract] [Full Text] [Related]

  • 24. From the Centers for Disease Control and Prevention. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
    JAMA; 2009 Jan; 285(4):402-3. PubMed ID: 11263401
    [No Abstract] [Full Text] [Related]

  • 25. The use of a triple nucleoside-nucleotide regimen for nonoccupational HIV post-exposure prophylaxis.
    Winston A, McAllister J, Amin J, Cooper DA, Carr A.
    HIV Med; 2005 May; 6(3):191-7. PubMed ID: 15876286
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Tolerability of HIV postexposure prophylaxis among healthcare workers.
    Kiertiburanakul S, Wannaying B, Tonsuttakul S, Kehachindawat P, Apivanich S, Somsakul S, Malathum K.
    J Hosp Infect; 2006 Jan; 62(1):112-4. PubMed ID: 16099546
    [No Abstract] [Full Text] [Related]

  • 31. HIV postexposure prophylaxis: new recommendations.
    Patrick DM.
    CMAJ; 1997 Jan 15; 156(2):233-4. PubMed ID: 9012728
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Nucleoside-analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir for pretreated children infected with human immunodeficiency virus type 1.
    Krogstad P, Lee S, Johnson G, Stanley K, McNamara J, Moye J, Jackson JB, Aguayo R, Dieudonne A, Khoury M, Mendez H, Nachman S, Wiznia A, Pediatric AIDS Clinical Trials Group 377 Study Team.
    Clin Infect Dis; 2002 Apr 01; 34(7):991-1001. PubMed ID: 11880966
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cryptococcal meningoradiculitis: an atypical presentation after initiation of antiretroviral therapy.
    Jongwutiwes U, Malathum K, Sungkanuparph S.
    J Med Assoc Thai; 2007 Nov 01; 90 Suppl 2():85-8. PubMed ID: 19230429
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Efficacy of a generic fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) in Thai HIV-infected patients.
    Kiertiburanakul S, Khongnorasat S, Rattanasiri S, Sungkanuparph S.
    J Med Assoc Thai; 2007 Feb 01; 90(2):237-43. PubMed ID: 17375626
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.